MacroGenics, Inc.

US$2.33As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:MGNXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (20.66%)
Div yield —
ROE (225.85%)
Biotechnology
Beta (5Y) 1.32
PE TTM —
TSR TTM 40.36%
Mkt cap US$148.4M
ROIC (29.40%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.89
23.84%
(34.47%)
Hold 5|8|4|5|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.03
0.02
0.03
17.36%
22.26%
7.84%
13.38%
Revenue$M
7.382
7.513
7.599
7.972
5.53%
5.23%
8.29%
12.60%
Peers (US$148.4M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.756
0.040
0.039
EBIT/Intx
1.156
0.142
0.154
Own earn%
114.84
(74.59)
(79.81)
Sh yield%
42.01
33.67
33.06
Owners
Insiders/Inst%
6.48
60.01
Short interest%
0.59
SBC / revenue%
2.56
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
18–23
$1 testx
—
Incr. ROIC%
26